DaVita Inc
TRL
Company Profile
Business description
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Contact
2000 16th Street
DenverCO80202
USAT: +1 720 631-2100
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2026
Employees
78,000
Stocks News & Analysis
stocks
Older cohorts the budget losers, not necessarily the ASX listed insurers
Proposed legislation removes health insurance rebates.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,823.90 | 11.70 | 0.13% |
| CAC 40 | 7,987.49 | 0.00 | 0.00% |
| DAX 40 | 24,307.92 | 357.35 | 1.49% |
| Dow JONES (US) | 49,686.12 | 159.95 | 0.32% |
| FTSE 100 | 10,323.75 | 128.38 | 1.26% |
| HKSE | 25,749.12 | 73.94 | 0.29% |
| NASDAQ | 26,090.73 | 134.41 | -0.51% |
| Nikkei 225 | 60,677.08 | 138.87 | -0.23% |
| NZX 50 Index | 12,912.36 | 149.44 | 1.17% |
| S&P 500 | 7,403.05 | 5.45 | -0.07% |
| S&P/ASX 200 | 8,601.40 | 19.80 | 0.23% |
| SSE Composite Index | 4,132.46 | 0.93 | 0.02% |